Paraoxonase-1 and oxidative status in common Mediterranean β-thalassaemia mutations trait, and their relations to atherosclerosis

Journal of Clinical Pathology

Volumn 64, Issue 5, 2011, Pages 437-442

  Labib, Hany A ^a   Etewa, Rasha Lotfi ^b   Gaber, Osama A ^b   Atfy, Maha ^a   Mostafa, Tamer M ^b   Barsoum, Ihab ^b  

^a Zagazig University   (Egypt)

^b ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; MALONALDEHYDE;

ADULT; ANEMIA; ANTIOXIDANT ACTIVITY; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CAROTID ARTERY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENZYME ACTIVITY; FEMALE; GENE MUTATION; GENETIC TRAIT; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; THALASSEMIA MAJOR;

ADULT; ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; ATHEROSCLEROSIS; BETA-THALASSEMIA; CAROTID ARTERIES; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MALONDIALDEHYDE; MATCHED-PAIR ANALYSIS; OXIDATIVE STRESS; REFERENCE VALUES; TUNICA INTIMA; TUNICA MEDIA;

EID: 79955097145     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2011.090209     Document Type: Article

References (40)

1. Higgs DR, Thein SL, Woods WG. The molecular pathology of the thalassemias. In: Weatherall DJ, Clegg B, eds. The Thalassemia Syndromes, 4th edn. Oxford: Blackwell Science, 2001:133-91.
2. Schawartz CJ, Valente AJ. The pathogenesis of atherosclerosis. In: Frei B, ed. Natural antioxidants in human health and disease. New York, NY: Academic Press, 1994:287-94.
3. Sonakul D, Suwanagool P, Sirivaidyapong P, et al. Distribution of pulmonary thromboembolic lesions in thalassemic patients. Birth Defects Orig Artic Ser 1987;23:375-84.
4. Steinberg D, Parthasaraty S, Carew TE, et al. Beyond cholesterol. Modification of low density lipoprotein that increases atherogenicity. N Engl J Med 1989;320:915-24. (Pubitemid 19101597)
5. Schawartz CJ, Valente AJ. The pathogenesis of atherosclerosis. In: Frei B, ed. Natural antioxidants in human health and disease. New York, NY: Academic Press, 1994:287-94.
6. Navab M, Ananthramaiah GM, Reddy ST, et al. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res 2004;45:993-1007. (Pubitemid 38679495)
7. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43. (Pubitemid 34212626)
8. Watson AD, Berliner JA, Hama SY, et al. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest 1995;96:2882-91.
9. Mackness MI, Arrol S, Abbott C, et al. Protection of low density lipoprotein against oxidative modification by high density lipoprotein associated paraoxonase. Atherosclerosis 1993;104:129-35. (Pubitemid 24035640)
10. La Du BN. Structural and functional diversity of paraoxonase. Nat Med 1996;2:1186-7.
11. Tavori H, Aviram M, Khatib S, et al. Human carotid atherosclerotic plaque increases oxidative state of macrophages and low-density lipoproteins, whereas paraoxonase 1 (PON1) decreases such atherogenic effects. Free Radic Biol Med 2009;46:607-15.
12. Rosenblat M, Gaidukov L, Khersonsky O, et al. The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux. J Biol Chem 2006;281:7657-65. (Pubitemid 43847536)
13. Durrington PN, Mackness B, Mackness MI. Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol 2001;21:473-80. (Pubitemid 32323376)
14. Raitakari OT, Juonala M, Taittonen L, et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood, The cardiovascular risk in young finns tudy. JAMA 2003;290:2277-83. (Pubitemid 37430560)
15. Weatherall DJ. The thalassaemias. In: Beutler E, Lichtman MA, Coller BS, et al, eds. Williams's Hematology. New York: McGraw-Hill, 1995:581-615.
16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
17. Mackness MI, Harty D, Bhatmigar D, et al. Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. Atherosclersis 1991;86:193-9.
18. Koraccvic D, Koracevic G, Djordjevie V, et al. Method for the measurement of antioxidant activity in human fluids. J Clin Pathol 2001;54:356-61. (Pubitemid 32458132)
19. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-8. (Pubitemid 9194347)
20. Selek S, Aslan M, Horoz M, et al. Oxidative status and serum PON1 activity in beta-thalassemia minor. Clin Biochem 2007;40:287-91.
21. Vives Corrons JL, Miguel-Garcia A, Pujades MA, et al. Increased susceptibility of microcytic red blood cells to in vitro oxidative stress. Eur J Haematol 1995;55:327-31.
22. Kassab-Chekir A, Laradi S, Ferchichi S, et al. Oxidants, antioxidant status and metabolic data in patients with beta-thalassemia. Clin Chem Acta 2003;338:79-86. (Pubitemid 37456693)
23. Steinberg D. Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. Circulation 1997;95:1062-71.
24. Calandra S, Bertolini S, Pes GM, et al. Beta-thalassemia is a modifying factor of the clinical expression of familial hypercholesterolemia. Semin Vasc Med 2004;4:271-8. (Pubitemid 40094492)
25. Brizzi P, Isaja T, D'Agata A, et al. Oxidized LDL antibodies (OLAB) in patients with beta-thalassemia major. J Atheroscler Thromb 2002;9:139-44.
26. Aviram M, Hardak E, Vaya J, et al. Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. Circulation 2000;101:2510-17. (Pubitemid 30366256)
27. Ahmed Z, Ravandi A, Maguire GF, et al. Multiple substrates for paraoxonase-1 during oxidation of phosphatidylcholine by peroxynitrite. Biochem Biophys Res Commun 2002;290:391-6. (Pubitemid 34694511)
28. Jarvik GP, Tsai NT, McKinstry LA, et al. Vitamin C and E intake is associated with increased paraoxonase activity. Arterioscler Thromb Vasc Biol 2002;22:1329-33. (Pubitemid 34875745)
29. Zurlo MG, Stefano PD, Borgna-Pignatti C, et al. Survival and causes of death in thalassaemia major. Lancet 1989;2:27-30. (Pubitemid 19158169)
30. McGill HC Jr, McMahan CA, Herderick EE, et al. Effects of coronary heart disease risk factors on atherosclerosis of selected regions of the aorta and right coronary artery. PDAY Research Group. Pathobiological determinants of atherosclerosis in youth. Arterioscler Thromb Vasc Biol 2000;20:836-45.
31. Berenson GS, Srinivasan SR, Bao W, et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults: the Bogalusa Heart Study. N Engl J Med 1998;338:1650-6. (Pubitemid 28267909)
32. Dhawan V, Kumar KHR, Marwaha RK, et al. Antioxidant status in children with homozygous thalassemia. Indian Pediatr 2005;42:1141-5. (Pubitemid 43373140)
33. Chakraborty D, Bhattacharyya M. Antioxidant defense status of red blood cells of patients with β thalassemia and Ebeta-thalassemia. Clin Chim Acta 2001;305:123-9. (Pubitemid 32201969)
34. Ghone RA, Kumbar KM, Suryakar AN, et al. Oxidative stress and disturbance in antioxidant balance in beta thalassemia major. Ind J Clin Biochem 2008;23:337-40.
35. Cakmak A, Soker M, Koc A, et al. Paraoxonase and arylesterase activity with oxidative status in children with thalassemia major. J Pediatr Hematol Oncol 2009;31:583-7.
36. Comporti M, Signorini C, Buonocore G, et al. Iron release, oxidative stress and erythrocyte ageing. Free Radic Biol Med 2002;329:568-76. (Pubitemid 34241489)
37. Nobilia B, Perrottaa S, Mataresea SMR, et al. Evaluation of body iron status in Italian carriers of beta-thalassemia trait. Nutr Res 2001;21:55-60.
38. Khattak I, Khattak ST, Khan J. Heterozygous beta thalassemia in parents of children with beta thalassemia major. Gomal J Med Sci 2006;4:52-6.
39. Laksmitawati DR, Handayani S, Udyaningsih-Freisleben SK, et al. Iron status and oxidative stress in beta-thalassemia patients in Jakarta. Biofactors 2003;19:53-62. (Pubitemid 38073144)
40. Haj Khelil A, Laradi S, Nabli N, et al. Paramètres biochimiques chez les β-thalassémiques. Immunol Anal Biol Spec 2001;16:315-20.